Maria-Victoria Mateos

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Maria-Victoria Mateos
Jan 13, 2025, 09:37 | Science
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
Al-Ola A Abdallah, Plasma Cell Disorder Program Director, Division of HMCT/University of Kansas Medical Center, shared…
Jan 9, 2025, 13:33 | Science
Myeloma Paper of the Day, January 9th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Phase 1b-2 study of…
Dec 19, 2024, 21:31 | Science
Vincent Rajkumar: AQUILA is my 12th published randomized trial
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, posted on X…
Dec 11, 2024, 19:11 | Drugs
Results of AQUILA Trial: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Daratumumab, an anti-CD38 monoclonal antibody, has been approved for treating multiple myeloma. On December 9th…
Dec 11, 2024, 08:56 | Insight
The AQUILA study from ASH24 is out - IACH
The International Academy for Clinical Hematology (IACH) shared a post on X: “Breaking News: the…
Dec 10, 2024, 11:15 | Blog
Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, posted on X…
Dec 4, 2024, 14:15 | Insight
Myeloma Paper of the Day, December 4th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: A systematic review and meta-analysis…
Nov 8, 2024, 13:40 | Insight
Myeloma Paper of the Day, November 8th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Results of a Phase 1b…
Oct 28, 2024, 06:36 | Positive
CARVYKTI® (ciltacabtagene autoleucel) was Awarded the Johnson Medal
Carvykti®: A Personalized Medicine Delivered Through a One-Time Infusion CARVYKTI® has been recognized with the Johnson…
Oct 24, 2024, 20:28 | Blog
Vincent Rajkumar: Trials with bispecifics for myeloma going on in all stages of the disease
Vincent Rajkumar shared on X: ''Trials with bispecifics for myeloma going on in all stages…
Oct 22, 2024, 14:34 | Insight
Myeloma Paper of the Day, October 22nd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of the impact…
Sep 19, 2024, 10:02 | Insight
Myeloma Paper of the Day, September 19th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Study of data from the GEM2012MENOS65…
Jul 25, 2024, 00:44 | Opinion
Manni Mohyuddin: The results of the GEM-CESAR trial are a stunning verdict against early intervention in SMM
Manni Mohyuddin shared on X: "The GEM-CESAR trial of a super aggressive approach to SMM…
Jul 23, 2024, 13:25 | Insight
Myeloma Paper of the Day, July 23rd, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: KRd induction, ASCT, KRd consolidation, & Rd…
Jul 22, 2024, 03:26 | Insight
Humberto Martinez-Cordero: Our article on myeloma disparities has been accepted in Current Opinion in Oncology
Humberto Martinez-Cordero, Hematologist at the National Cancer Institute – ESE, shared a post on X:…
Jul 12, 2024, 13:01 | Insight
Myeloma Paper of the Day, July 12th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Study of single-point and kinetics…
May 10, 2024, 01:01 | Insight
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
All: 17 Posts: 1 - 100
Special Coverage